Jardine Matheson Holdings Ltd. is arranging a loan of roughly A$1.5 billion (about $1.1 billion) to finance the purchase of Australian diagnostic imaging provider I‑MED Radiology Network Ltd. Insiders say the facility will be syndicated among major Asian banks, underscoring confidence in Jardine’s credit standing. The deal could merge I‑MED’s platform with Jardine’s health assets, creating cross‑selling opportunities across its Asian network.

Jardine's move follows recent deals aimed at diversifying revenue as core trading and property growth slows. Adding I‑MED’s imaging centres gives the group exposure to Australia’s private‑health market, where expenditure rose 4% year‑over‑year amid an aging population and higher insurance uptake, outpacing many neighboring economies. The sector accounts for roughly 10% of Australia’s health‑care spend, positioning I‑MED as a sizeable player.

Securing the loan is a decisive step before the deal closes, as lenders scrutinize I‑MED’s EBITDA margins, which have shown double‑digit growth. Completion would lift Jardine’s healthcare assets above $2 billion, sharpening its competitive stance against regional rivals expanding into medical services and may draw further equity interest from global investors and could improve leverage ratios for the conglomerate.